Skip to content

Dry Needling vs. Acupuncture

Main result

36.7%

Minor adverse events

The International Journal of Sports Physical Therapy · Boyce et al. · 2020 · 420 participants

Adverse Events Associated with Therapeutic Dry Needling

Moderate
  • <0.1%

    Major adverse events

  • 16.0 %

    Bleeding (most common)

Study design sheet

  • Prospective Study
  • n=420 practitioners
  • High Clinical Impact
Participants
420

n = 420; median of studies with the same design: 96

Duration

6 weeks

6 weeks of data collection

Groups
  • Certified practitioners (420)Self-report of adverse events during dry needling
OBJECTIVE
To determine and report the types of adverse events associated with therapeutic dry needling
TREATMENTS
20,494 dry needling sessions analyzed
Results in numbers
  • 36.7 %Minor adverse events
  • <0.1%Major adverse events
  • 16.0 %Bleeding (most common)
  • 7.7 %Hematomas
  • 5.9 %Pain during needling
Outcome comparison
  • Rate of minor adverse events
    • Dry needling (current study): 36.7 of 100
    • Brady et al study (2014): 19 of 100

What does this mean for you?

In this study, serious events with dry needling were rare (less than 1 case per 1,000 treatments), although small bleeds and hematomas are common (occurring in about 1 in 4 treatments). According to the authors, the risk of a serious event is much lower than the adverse event rates reported in the literature for medications such as opioids and NSAIDs, but the comparison is indirect.

Article summary

Plain-language narrative summary

Dry needling is a technique that uses thin filiform needles to stimulate myofascial trigger points, differing from acupuncture by focusing on specific muscular structures rather than energy meridians. The methodology involved prospective data collection over six weeks, with practitioners completing weekly electronic questionnaires about minor adverse events (bleeding, hematomas, pain) and major events (pneumothorax, infections, prolonged worsening). Participants had a mean age of 38 years, with 12.1 years of professional practice and 2.7 years of practicing dry needling. The majority (82%) worked in orthopedic clinics.

The results showed that minor adverse events occurred in 36.7% of treatments, with bleeding (16%), hematomas (7.7%), and pain during the procedure (5.9%) being the most frequent. These events are considered normal and expected after needle insertion. Major adverse events were extremely rare, occurring in less than 0.1% of cases (approximately 1 in 1,000 treatments). The most reported major events included prolonged worsening of symptoms, fainting, and forgotten needles in the patient.

Notably, there was no association between the frequency of adverse events and practitioner characteristics such as age, education, years of practice, or level of training. In the discussion, the authors cite adverse event rates reported in the literature for other pain treatments (opioids, 78%; NSAIDs, 35%) and consider the risk of a major adverse event with dry needling to be drastically lower, although this is an indirect comparison with studies using different methods. This study significantly expanded the knowledge of safety, since previous studies were limited—Brady et al. (2014) analyzed only 39 therapists and found no major events, possibly due to insufficient sample size.

The clinical implications are important: qualified practitioners can advise patients that minor events such as light bleeding are expected, but serious complications are extremely rare. The study recommends that practitioners develop protocols to track used needles, prepare to manage vasovagal responses, and adequately inform patients about risks. In the context of the opioid epidemic, the authors state that safe and effective treatment alternatives must be explored and conclude that dry needling poses little harm to a patient when performed by a trained practitioner.

Strengths

  • Large sample with more than 20,000 treatments analyzed
  • Prospective design with real-time data collection
  • Anonymity of participants allowing honest reporting
  • Clear categorization between minor and major events
  • Comparison with adverse event rates of other pain treatments reported in the literature

Limitations

  • Low response rate (3%) potentially generating selection bias
  • Self-report by therapists may underestimate events
  • Definitions of minor adverse events are not very specific
  • Decline in event reporting over the 6 weeks
  • Convenience sample limiting generalization
Dr. Marcus Yu Bin Pai

Expert Commentary

Clinical Relevance

The safety profile of dry needling across more than 20,000 sessions provides exactly the type of data we need to support the risk-benefit conversation with patients and service managers. Minor adverse events in 36.7% of treatments—predominantly mild bleeding and hematomas—are biologically expected after the insertion of a filiform needle into vascularized tissue and do not, in practice, constitute barriers to continuing treatment. The number that really weighs in clinical decision-making is that of major events: less than 0.1%. When we compare it to the profile of nonsteroidal anti-inflammatory drugs and, especially, opioids, dry needling emerges as a substantially lower-risk option for musculoskeletal pain. In the context of the opioid epidemic, the authors themselves emphasize the need to explore safe and effective treatment alternatives.

Notable Findings

Two findings are particularly striking. First, the absence of association between frequency of adverse events and practitioner characteristics—age, years of experience, level of training—suggests that the inherent risk of the procedure is relatively constant once basic competence is established, which simplifies reasoning about minimum required credentialing. Second, among major events, the most representative were prolonged worsening of symptoms, vasovagal syncope, and forgotten needles in the patient—not pneumothorax or serious infections, as the lay imagination tends to anticipate. This redirects preventive efforts: the safety protocol that matters most is not surgical preparation, but rather rigorous tracking of needles used per session and routine management of vasovagal responses, which any pain service should already have incorporated.

From My Experience

In my practice, I have used dry needling of trigger points integrated into the musculoskeletal rehabilitation program for more than fifteen years, and the adverse event profile described in this study is consistent with what we observe in our service. Pinpoint bleeding and discrete hematomas are so common that we include them in the informed consent as expected outcomes, not as complications. I typically see significant clinical response from the third or fourth session, with a complete cycle usually lasting between eight and twelve sessions for chronic myofascial pain. For vasovagal syncope—the most preventable major event—we adopt the protocol of mandatory reclined position for patients with a history of lipothymia or high procedural anxiety. I systematically combine with eccentric exercise and, when applicable, with periarticular block; I rarely indicate isolated needling. The patient who responds best, in my experience, is the one with localized myofascial pain and a palpable taut band, without predominant central component—in these cases, the expectation of response is high and the risk, as this work documents, is genuinely low.

Dr. Marcus Yu Bin Pai · MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

The International Journal of Sports Physical Therapy · 2020

DOI: 10.26603/ijspt20200103

Access original article

Scientific review

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.

  • Strong
  • Moderate
  • Limited
  • Weak
19801990200020102020
This study among the Library’s studiesEach dot is a study: left to right, the publication year; top to bottom, the study design, from meta-analyses to preclinical work; colour and shape give the level of evidence. Highlighted: the Dry Needling vs. Acupuncture studies.
See the numbers: This study among the Library’s studies
Study designDry Needling vs. AcupunctureAll studies
Meta-analysis · Systematic Review11387
RCT20224
Clinical Guideline05
Observational438
Case Series17
Narrative Review7155
Preclinical / Animal06
Other7203
See the Dry Needling vs. Acupuncture studies in the Library

Related articles

Based on this article’s categories

  1. Pai et al. · PAIN Reports · 2021

    • Dry Needling vs. Acupuncture
    • Neck & Shoulder Pain
    • Clinical Trial Methodology
  2. Brown et al. · Journal of Manual & Manipulative Therapy · 2025

    • Dry Needling vs. Acupuncture
    • Neck & Shoulder Pain
    • Clinical Trial Methodology
  3. dos Santos Maciel et al. · BMC Complementary and Alternative Medicine · 2016

    • Clinical Trial Methodology
    • Safety & Adverse Events
  4. Duan et al. · BMJ Evidence-Based Medicine · 2026

    • Clinical Trial Methodology
    • Safety & Adverse Events
    • Systematic Reviews & Meta-Analyses